|
C13ORF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.91869999782912E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.95249999945801E-07 |
| Normal-vs-Stage2 |
1.027660E-02 |
| Normal-vs-Stage3 |
1.290490E-02 |
| Normal-vs-Stage4 |
5.671000E-01 |
| Stage1-vs-Stage2 |
7.900000E-01 |
| Stage1-vs-Stage3 |
8.515000E-01 |
| Stage1-vs-Stage4 |
1.708780E-01 |
| Stage2-vs-Stage3 |
9.467800E-01 |
| Stage2-vs-Stage4 |
3.714200E-01 |
| Stage3-vs-Stage4 |
3.850000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.30560000033419E-07 |
| Normal-vs-AfricanAmerican |
1.85491999999954E-05 |
| Normal-vs-Asian |
4.538600E-01 |
| Caucasian-vs-AfricanAmerican |
9.047400E-01 |
| Caucasian-vs-Asian |
6.642400E-01 |
| AfricanAmerican-vs-Asian |
6.204400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5854999979581E-08 |
| Normal-vs-Female |
4.202100E-04 |
| Male-vs-Female |
2.265000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.019640E-03 |
| Normal-vs-Extreme_Weight |
2.7100000021818E-10 |
| Normal-vs-Obese |
2.760900E-04 |
| Normal-vs-Extreme_Obese |
6.397200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.834400E-02 |
| Normal_Weight-vs-Obese |
9.676800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.570200E-01 |
| Extreme_Weight-vs-Obese |
8.201600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.068750E-01 |
| Obese-vs-Extreme_Obese |
2.462200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.32139999997616E-06 |
| Normal-vs-Age(41-60Yrs) |
2.35859999999644E-05 |
| Normal-vs-Age(61-80Yrs) |
4.7953000015255E-08 |
| Normal-vs-Age(81-100Yrs) |
1.661590E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.435170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.109400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.408400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.724350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.118000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.191600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.90539830977355E-11 |
| Normal-VS-Type2 PRCC |
2.878600E-01 |
| Normal-VS-KIRP CIMP |
6.444600E-04 |
| Normal-VS-Unclassified PRCC |
1.027420E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.439650E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.836100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.431200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.089560E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.604400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.783580E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.702750E-03 |
| Normal-vs-N1 |
5.387800E-02 |
| Normal-vs-N2 |
1.331990E-01 |
| N0-vs-N1 |
8.196600E-01 |
| N0-vs-N2 |
3.019800E-01 |
| N1-vs-N2 |
3.105200E-01 |
|
|
